National Haemovigilance Office
What is the National Haemovigilance Office?
The National Haemovigilance Office was set up by the IBTS and launched by the Minister for Health and Children in 1999. The purpose of a haemovigilance programme is to identify unexpected or undesirable effects of transfusion of blood components by ensuring they are reported in a timely and reliable manner.
The NHO was also charged with promotion of best transfusion practice in hospitals throughout Ireland, through advice, guidelines and education.
Definition of Haemovigilance
A set of organised surveillance procedures relating to serious adverse or unexpected events or reactions in donors or recipients and the epidemiological follow-up of donors (EC Directive 2002/98/EC).
Remit of the Office
The remit of the NHO is to:
- Receive, collate and follow up reports from hospitals and general practitioners of adverse reactions/events connected with transfusion of blood components/products and provide feedback information to those making the report as appropriate.
- Advise on the follow-up action necessary, particularly with regard to suspected hazards.
- Report adverse reaction to the HPRA according to an agreed procedure.
- Provide ongoing support to hospital- based Haemovigilance Officers and as appropriate to medical nursing and technical staff.
- Provide medical, scientific and nursing analysis of adverse reaction reports.
- Advise on improvements on the safety of transfusion practice based on the data made available by hospitals.
- Support development of clinical guidelines for hospitals in relation to the use of blood components/products.
- Support as appropriate the training of medical, nursing and technical staff in haemovigilance.
- Support the audit function of hospitals in relation to transfusion practice
- Report to the National Blood Users Group on a periodic basis with a view to developing national best transfusion practice.
- A major part of the remit is education, training and support in relation to best transfusion practice at hospital level.
What's New at the NHO
- 18th International Haemovigilance Seminar July 2018 See IHS Website
- NHO Conference Presentations 2016 See Events Page
- ISBT Working Party on Haemovigilance Definition document
- 2016 - COMMON APPROACH FOR DEFINITION OF REPORTABLE SERIOUS ADVERSE EVENTS AND REACTIONS AS LAID DOWN IN THE DIRECTIVE 2002/98/EC1 (THE BLOOD DIRECTIVE) AND COMMISSION DIRECTIVE 2005/61/EC2 VERSION 5.2 (2016) Document
- Haemovigilance initial report form - see Reporting to the NHO
- Reporting SAE/Near Miss from Hospital Blood Bank or Blood Establishment - see Reporting to the NHO page
Haemovigilance Officers (HVO):
- Róisín Brady
- Joanne Scanlon
Office Administrator - Siobhan Conlon
You can contact us at email@example.com